Related Experiment Video
Updated: Jul 7, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Study on ascitic fluid complement 3 level in cirrhotic patients with spontaneous bacterial peritonitis and without
Golam Mustafa1, Mobin Khan, Khorshed Alam
1Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh. m_golam@yahoo.com
Insights
Low ascitic fluid Complement 3 (C3) levels indicate a higher risk of spontaneous bacterial peritonitis (SBP) in cirrhotic patients. This study found significantly reduced C3 concentrations in patients with SBP.
Area of Science:
- Immunology
- Hepatology
- Clinical Medicine
Background:
- Ascitic fluid Complement 3 (C3) is crucial for local defense against infection.
- Advanced cirrhosis significantly reduces hepatic synthesis and ascitic fluid C3 levels.
- Spontaneous bacterial peritonitis (SBP) is a serious complication in cirrhotic patients.
Purpose of the Study:
- To assess ascitic fluid C3 levels in cirrhotic patients with and without SBP.
- To identify cirrhotic ascites at risk of developing SBP.
- To evaluate the diagnostic role of ascitic fluid C3 in SBP.
Main Methods:
- Prospective case-control study design.
- Comparison of ascitic fluid C3 levels between SBP and non-SBP groups.
- Measurement of C3 concentration in 15 SBP patients (cases) and 15 non-SBP patients (controls).
Main Results:
- Ascitic fluid C3 concentration was significantly lower in patients with SBP (7.3+/-4.3 mg/dL) compared to those without SBP (16.4+/-11.3 mg/dL).
- A statistically significant difference (P=0.009) was observed in C3 levels between the two groups.
Conclusions:
- Ascitic fluid C3 levels are significantly reduced in cirrhotic patients who develop SBP.
- Low ascitic fluid C3 may serve as a biomarker for predicting SBP risk in cirrhosis.
- Monitoring C3 levels could aid in managing infection risk in cirrhotic ascites.
Background/Aims:
Ascitic fluid Complement 3 (C3) concentration is the most important factor to offer local defense against infection of ascitic fluid. Hepatic synthesis of Complement 3 and its concentration in ascitic fluid is significantly reduced in patients with advanced cirrhosis. The aim of the study was to assess the level of Complement 3 in ascitic fluid in cirrhotic patients with and without spontaneous bacterial peritonitis (SBP) and to identify the group of cirrhotic ascites at risk of developing
Methodology:
A prospective case control study was carried out to compare the level of ascitic fluid Complement 3 concentration in patients with SBP (case-group) and without SBP (control-group). Ascitic fluid Complement 3 level was estimated in 15 patients with SBP (case) and another 15 patients without SBP (control).
Results:
In the study, ascitic fluid Complement 3 concentration was 7.3+/-4.3 mg/dL in patients with SBP and 16.4+/-11.3 mg/dL in patients who did not develop SBP.
Conclusions:
Ascitic fluid Complement 3 level is significantly (P=0.009) reduced in cirrhotic patients who develop SBP.
Related Concept Videos
Ascites
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
